|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/705 | |
| C12N 15/28 | |||
| C12N 15/63 |
| (11) | Patento numeris | 2492281 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10825175.2 |
| Europos patento paraiškos padavimo data | 2010-10-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-08-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2010/007160 |
| Data | 2010-10-19 |
| (87) | Numeris | WO 2011/049350 |
| Data | 2011-04-28 |
| (30) | Numeris | Data | Šalis |
| 20090099219 | 2009-10-19 | KR |
| (72) |
KIM, Sung WuK, KR
JUN, Sung Soo, KR
PARK, Seung Kook, KR
KIM, Song Young, KR
KIM, Eun Sun, KR
JEONG, Jae Kap, KR
KIM, Ha Na, KR
SONG, Yeon Jung, KR
|
| (73) |
HanAll Biopharma Co., Ltd.,
400-1 Sangseo-dong Daedeok-gu, Daejeon 306-120,
KR
|
| (54) | MODIFIED HUMAN TUMOR NECROSIS FACTOR RECEPTOR-1 POLYPEPTIDE OR FRAGMENT THEREOF, AND METHOD FOR PREPARING SAME |
| MODIFIED HUMAN TUMOR NECROSIS FACTOR RECEPTOR-1 POLYPEPTIDE OR FRAGMENT THEREOF, AND METHOD FOR PREPARING SAME |